Addressing AI Bias in Medical Settingsby Lilu Anderson 14.08.2024Exploring the impact of AI bias in healthcare and solutions to ensure equitable patient care.
Fortress Biotech Reports Q2 2024 Financial Highlightsby Lilu Anderson 14.08.2024Fortress Biotech reveals Q2 2024 financials with key FDA updates; NDA and BLA filings signal growth in dermatology and oncology.
Castle Biosciences Q2: Revenue Soars 74% to $87 Millionby Mark Eisenberg 06.08.2024Castle Biosciences reports 74% Q2 revenue surge to $87M, driven by test usage and price hikes, with net income rebounding ...
7 Breakthrough Biotech Stocks to Boost Your Portfolio in 2023by Lilu Anderson 18.06.2024"Discover 7 breakthrough biotech stocks poised to boost your portfolio in a sector projected to reach $521.6B by 2033. Learn ...
Medicxi Launches Alys Pharmaceuticals in $100m Seed Fundingby Mark Eisenberg 19.02.2024Medicxi launches Alys Pharmaceuticals with $100m funding to develop groundbreaking therapies in immunodermatology. The company aims to address unmet needs ...